Compare SFIX & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SFIX | YDES |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 510.6M | 543.0M |
| IPO Year | 2017 | N/A |
| Metric | SFIX | YDES |
|---|---|---|
| Price | $3.76 | $2.47 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 344.1K |
| Earning Date | 06-09-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.44 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,226,505,000.00 | N/A |
| Revenue This Year | $8.04 | N/A |
| Revenue Next Year | $3.73 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.52 | N/A |
| 52 Week Low | $2.95 | $1.70 |
| 52 Week High | $5.92 | $25.00 |
| Indicator | SFIX | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 48.24 | 46.64 |
| Support Level | $3.43 | $2.14 |
| Resistance Level | $3.78 | $3.05 |
| Average True Range (ATR) | 0.17 | 0.41 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 26.96 | 57.04 |
Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.